Barriers to healthcare in a multiethnic cohort of systemic lupus erythematosus (SLE) patients: Patient and physician perceptions

Clinical Medicine: Arthritis and Musculoskeletal Disorders

Volumn 2009, Issue 2, 2009, Pages 1-8

  Law, Genevieve ^a   Pope, Janet ^a   Lalani, Sheliza ^a   Silverman, Earl ^b   Cooper, Glinda ^c   Fortin, Paul ^d   Zummer, Michel ^e   Smith, C Douglas ^f   Petty, Ross ^g   Tucker, Lori ^g   Albert, Lori ^d   Huber, Adam ^h   Ramsey, Susanne ^h   Arbillaga, Hector ⁱ   Chedéville, Gaëlle ^j   Hudson, Marie ^j   Peschken, Christine ^k  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

^e MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^f UNIVERSITY OF OTTAWA   (Canada)

^g UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^h DALHOUSIE UNIVERSITY   (Canada)

ⁱ UNIVERSITY OF CALGARY   (Canada)

^j MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^k UNIVERSITY OF MANITOBA   (Canada)

more..

Author keywords

Canadian Network for Improved Outcomes in SLE (CaNIOS); Healthcare barriers; Systemic lupus erythematosus (SLE)

Indexed keywords

ABORIGINE; ADULT; ARTICLE; ASIAN; CAUCASIAN; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DATA ANALYSIS; DEMOGRAPHY; DISEASE ACTIVITY; DOCTOR PATIENT RELATION; DRUG COST; ETHNIC GROUP; FEMALE; HEALTH CARE ACCESS; HEALTH STATUS; HOUSEHOLD; HUMAN; INCOME; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MEDICAL SPECIALIST; NEGRO; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PHYSICIAN ATTITUDE; PREDICTION; SYSTEMIC LUPUS ERYTHEMATOSUS; TRAVEL;

EID: 77953388329     PISSN: None     EISSN: 11781149     Source Type: Journal    
DOI: 10.4137/cmamd.s2136     Document Type: Article

References (23)

1. Yazdany J, Gillis JZ, Trupin L, et al. Association of socioeconomic and demographic factors with utilization of rheumatology subspecialty care in systemic lupus erythematosus. Arthritis Rheum. 2007;57(4):593-600.
2. Yelin EH, Such CL, Criswell LA, et al. Outcomes for persons with rheumatoid arthritis with a rheumatologist versus a non-rheumatologist as the main physician for this condition. Med Care. 1998; 36:513-22.
3. Epstein WV, Curtis JH. The nature of U.S. rheumatology practice, 1977. Arthritis Rheum. 1981;24(9):1177-87.
4. Alarcon GS, McGwin G, Bastian HM, et al. Systemic Lupus Erythe-matosus in Three Ethnic Groups. VIII. Predictors of Early Mortality in the LUMINA Cohort. Arthritis Care Res. 2001;45:191-202.
5. Rojas-Serrano J, Cardiel MH. Lupus patients in an emergency unit. Causes of consultation, hospitalization, and outcome. A cohort study. Lupus. 2000;9:601-6.
6. Adler M, Chambers S, Edward C, et al. An assessment of renal failure in an SLE cohort with a special reference to ethnicity over a 25 year period. J Rheumatol. 2006;45(9):1144-7.
7. Karlson EW, Daltroy LH, Lew RA, et al. The relationship of socioeconomic status, race, and modifi able risk factors to outcomes in patients with systemic lupus erythematosus. Arthritis Rheum. 1997;40(1):47-56.
8. Ward MM. Medical insurance, socioeconomic status, and age of onset of endstage renal disease in patients with lupus nephritis. J Rheumatol. 2007;34(10):2024-7.
9. Katz JN, Barrett J, Liang MH, et al. Utilization of rheumatology physician services by the elderly. Am J Med. 1998;105(4):312-8.
10. Tan EM, Cohen AS, Fries JF, et al. The 1982 Revised Criteria for the Classifi cation of Systemic Lupus Erythematosus. Arthritis Rheum. 1982;25(11):1271-8.
11. Liang MH, Socher SA, Larson MG, et al. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum. 1989;32:1107-18.
12. Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992;35:630-40.
13. Gladman D, Ginzler E, Goldsmith C, et al. The Development and Initial Validation of The Systemic Lupus International Collaborating Clinics/ American College of Rheumatology Damage Index for Systemic Lupus Erythematosus. Arthritis Rheum. 1996;39(3):363-9.
14. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-83.
15. Petri M, Perez-Gutthann S, Longenecker JC, et al. Morbidity of systemic lupus erythematosus: role of race and socioeconomic status. Am J Med. 1991;4:345-53.
16. Fernandez M, Alarcon GS, Calvo-Alen J, et al. A multiethnic, multicenter cohort of patients with systemic lupus erythmatosus (SLE) as a model for the study of ethnic disparities in SLE. Arthritis Rheum. 2007;57(4):576-84.
17. Moses N, Wiggers J, Nicholas C, et al. Prevalence and correlates of perceived unmet needs of people with systemic lupus erythematosus. Patient Educ Couns. 2005;57(1):30-8.
18. Stockl A. Complex syndromes, ambivalent diagnosis and existential uncertainty: the case of Systemic Lupus Erythematosus (SLE). Soc Sci Med. 2007;65(7):1549-59.
19. Trethewey P. Systemic lupus erythematosus [Review]. Dimens Crit Care Nurs. 2004;23(3):111-5.
20. Alarcon GS, McGwin G Jr, Sanchez ML, et al. Systemic lupus erythematosus in three ethnic groups. XIV. Poverty, wealth, and their influence on disease activity. Arthritis Rheum. 2004;51:73-7.
21. Alarcon GS, Calvo-Alen J, McGwin G Jr, et al. Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXV. Predictive factors of high disease activity over time. Ann Rheum Dis. 2006;65:1168-74.
22. Gillis JZ, Yazdany J, Trupin L, et al. Medicaid and access to care among persons with systemic lupus erythematosus. Arthritis Rheum. 2007;57:601-7.
23. Karlson EW, Daltroy LH, Lew RA, et al. The independence and stability of socioeconomic predictors of morbidity in systemic lupus erythematosus. Arthritis Rheum. 1995;38:267-73.